Williams & Novak, LLC Eli Lilly & CO Transaction History
Williams & Novak, LLC
- $130 Billion
- Q3 2025
A detailed history of Williams & Novak, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Williams & Novak, LLC holds 509 shares of LLY stock, worth $439,195. This represents 0.3% of its overall portfolio holdings.
Number of Shares
509
Previous 428
18.93%
Holding current value
$439,195
Previous $334 Million
16.41%
% of portfolio
0.3%
Previous 0.28%
Shares
2 transactions
Others Institutions Holding LLY
# of Institutions
4,470Shares Held
779MCall Options Held
16.9MPut Options Held
12.6M-
Lilly Endowment Inc Indianapolis, IN95.5MShares$82.4 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA80.4MShares$69.4 Billion1.05% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$56.8 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$44.3 Billion26.07% of portfolio
-
State Street Corp Boston, MA34.5MShares$29.8 Billion1.04% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $820B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...